Aidite plans to invest 100 million yuan to establish an industrial fund, specifically for investing in Pute Medical.

Source: AIDITE Announcement on Joint Investment with Professional Investment Institutions

DentalGoodNews｜On April 24, 2026, Aidite (Qinhuangdao) Technology Co., Ltd. (hereinafter referred to as "Aidite") issued an announcement, declaring its intention to jointly invest with professional investment institutions to establish an industrial fund, specifically investing in the dental orthodontic materials enterprise Zhejiang Pute Medical Devices Co., Ltd. (hereinafter referred to as "Pute Medical").

According to the announcement, Aidite plans to jointly establish Jiaxing Chende Qinghe Equity Investment Partnership (Limited Partnership) (hereinafter referred to as the "Fund") with Jiaxing Chenzhen De Enterprise Management Partnership (Limited Partnership) and Wuxi Chenming De Investment Partnership (Limited Partnership). The total subscribed capital of the Fund is RMB 201 million, of which Aidite intends to subscribe RMB 100 million with its own funds, accounting for 49.75% of the total subscribed capital.

The target entity of this investment, Pute Medical, is a high-tech enterprise specializing in the R&D, production, and sales of dental orthodontic materials. Its main products include Orthodontic Brackets, dental implant materials, orthodontic auxiliary devices, and tools.

*Source: PUTE Medical 2025 Semi-Annual Report

According to Pute Medical's semi-annual report for 2025, the company achieved operating revenue of RMB 83 million in the first half of 2025, a year-on-year decrease of 3.93%; net profit attributable to shareholders of the listed company was RMB 30 million, a year-on-year increase of 11.85%. Among these, Orthodontic Bracket products generated revenue of RMB 64 million, down 3.11% year-on-year, with a gross margin of 79.72%, down 2.76% year-on-year; dental implant materials achieved revenue of RMB 7 million, down 5.71% year-on-year, with a gross margin of 77.13%, down 3.03% year-on-year; other product revenue was RMB 12 million, down 7.07% year-on-year, with a gross margin of 56.06%, up 1.58% year-on-year.

Additionally, according to DGN (Leading Dental Industry Media, DGN), Pute Medical had its application for termination of listing on the National Equities Exchange and Quotations (NEEQ) accepted in February 2026. Pute Medical stated that this move aims to further enhance decision-making efficiency, reduce operational costs, and integrate internal and external resources to focus on the development of its main business.

Aidite stated that this investment aligns with its overall development strategy, helping the company acquire high-quality industrial chain resources and expand its digital ecosystem operational layout in the field of Dental Restoration|Prosthodontics.

According to the partnership agreement, the Fund has an operational term of 6 years, comprising a 4-year investment period and a 2-year exit period. Currently, the Fund has not yet completed its fundraising efforts and still needs to undergo the filing process with the Asset Management Association of China.